KARYOPHARM THERAPEUTICS INC
KPTI · NASDAQ
Updated at 2026-10-13 15:18:11
- Today's High
- $0.50
- Today’s Low
- $0.42
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.59
- Previous Close
- $0.50
- Volume
- 898.6K
- Market Cap
- $11.45M
- P/E Ratio
- --
- EPS
- $-12.83
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 85 WELLS AVENUE, NEWTON, MA, UNITED STATES, 02459-3298
- Country
- US
- Listing Date
- 2013-11-06
- Fiscal Year End
- December
- Shares Outstanding
- 22.66M
- CIK
- 0001503802
- Website
- karyopharm.com
Karyopharm Therapeutics Inc., a pharmaceutical company, is dedicated to the discovery, development and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is headquartered in Newton, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$33.43M
2026-03-31
$35.06M
2025-12-31
$34.07M
2025-09-30
$44.04M
Operating Expenses
2026-06-30
$54.87M
2026-03-31
$60.46M
2025-12-31
$50.43M
2025-09-30
$57.15M
Net Income
2026-06-30
-$67.02M
2026-03-31
-$22.39M
2025-12-31
-$102.19M
2025-09-30
-$33.12M
Net Profit Margin
2026-06-30
-200.47%
2026-03-31
-63.85%
2025-12-31
-299.88%
2025-09-30
-75.21%
Earnings Per Share
2026-06-30
$-2.32
2026-03-31
$-1.24
2025-12-31
$-2.23
2025-09-30
$-3.82
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$53.88M
2026-03-31
-$9.82M
2025-12-31
-$89.62M
2025-09-30
-$22.51M
Effective Tax Rate
2026-06-30
--
2026-03-31
0%
2025-12-31
0.06%
2025-09-30
-0.1%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $33.43M | $35.06M | $34.07M | $44.04M |
| Operating Expenses | $54.87M | $60.46M | $50.43M | $57.15M |
| Net Income | -$67.02M | -$22.39M | -$102.19M | -$33.12M |
| Net Profit Margin | -200.47% | -63.85% | -299.88% | -75.21% |
| Earnings Per Share | $-2.32 | $-1.24 | $-2.23 | $-3.82 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$53.88M | -$9.82M | -$89.62M | -$22.51M |
| Effective Tax Rate | -- | 0% | 0.06% | -0.1% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.